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Abstract
Background: Improved delineation of vascular structures is a common indication for cardiovascular magnetic
resonance (CMR) in children and requires high spatial resolution. Currently, pre-contrast 3D, respiratory navigated,
T2-prepared, fat saturated imaging with a bSSFP readout (3D bSSFP) is commonly used; however, these images can
be limited by blood pool inhomogeneity and exaggeration of metal artifact. We compared image quality of
pediatric vasculature obtained using standard 3D bSSFP to 3D, respiratory navigated, inversion recovery prepared
imaging with a gradient echo readout (3D IR GRE) performed after administration of gadofosveset trisodium (GT), a
blood pool contrast agent.
Methods: For both sequences, VCG triggering was used with acquisition during a quiescent period of the cardiac
cycle. 3D bSSFP imaging was performed pre-contrast, and 3D IR GRE imaging was performed 5 min after GT
administration. We devised a vascular imaging quality score (VIQS) with subscores for coronary arteries, pulmonary
arteries and veins, blood pool homogeneity, and metal artifact. Scoring was performed on axial reconstructions of
isotropic datasets by two independent readers and differences were adjudicated. Signal- and contrast-to-noise (SNR
and CNR) calculations were performed on each dataset.
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Results: Thirty-five patients had both 3D bSSFP and 3D IR GRE imaging performed. 3D IR GRE imaging
showed improved overall vascular imaging compared to 3D bSSFP when comparing all-patient VIQS scores
(n = 35, median 14 (IQR 11–15), vs 6 (4–10), p < 0.0001), and when analyzing the subset of patients with
intrathoracic metal (n = 17, 16 (14–17) vs. 5 (2–9), p < 0.0001). 3D IR GRE showed significantly improved VIQS
subscores for imaging the RCA, pulmonary arteries, pulmonary veins, and blood pool homogeneity. In
addition, 3D IR GRE imaging showed reduced variability in both all-patient and metal VIQS scores compared
to 3D bSSFP (p < 0.05). SNR and CNR were higher with 3D IR GRE in the left ventricle and left atrium, but
not the pulmonary arteries.
Conclusions: Respiratory navigated 3D IR GRE imaging after GT administration provides improved vascular
CMR in pediatric patients compared to pre-contrast 3D bSSFP imaging, as well as improved imaging in
patients with intrathoracic metal. It is an excellent alternative in this challenging patient population when
high spatial resolution vascular imaging is needed.
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Background
The use of cardiovascular magnetic resonance (CMR) in
the pediatric population continues to increase, aided by
advancements in techniques that accommodate higher
heart rates and shorter scanning time. CMR spatial reso-
lution has improved and now approaches that of com-
puted tomography (CT). Improved delineation of vascular
structures, including coronary arteries and pulmonary
veins, is a common indication for CMR imaging in chil-
dren. However, this can be challenging given the need for
high spatial resolution and the small size of the structures
to be imaged.
Currently, pre-contrast 3D, respiratory navigated, T2
prepared, fat saturated imaging with a balanced steady-
state free precession readout (3D bSSFP) is commonly
used for imaging of pediatric vascular structures [1, 2].
Images generated by the 3D bSSFP technique, however,
often demonstrate blood pool inhomogeneity and exag-
gerate metal artifacts, which is especially challenging in
the congenital heart disease population. Imaging large fields
of view using the 3D bSSFP technique also requires pro-
longed scan times due to navigator inefficiency [3]. The
development and FDA approval of a protein-bound MR
contrast agent, gadofosveset trisodium (GT), has allowed
fundamental changes in the high spatial resolution,
3D pulse sequences. Protein binding allows for a lon-
ger duration of contrast effects, so that imaging dur-
ing an equilibrium phase achieves minimal to no
change in the degree of T1 shortening over the scan
duration. A 3D, respiratory-navigated, inversion recov-
ery prepared sequence with a gradient echo readout
(3D IR GRE) leverages this prolonged equilibrium
phase for vascular imaging.
Previous studies have compared MR angiography
(MRA) with gadofosveset trisodium to traditional gadobe-
nate dimeglumine contrast for coronary arteries in adults
at 3.0 T [4]; coronary artery imaging with gadofosveset tri-
sodium at 3.0 T compared to pre-contrast 3D SSFP
imaging at 1.5 T [1]; and for other angiography of carotid
[5], renal [6, 7], and iliofemoral arteries [6]. The use of
gadofosveset trisodium has shown advantages in each of
these situations. Some adult studies of gadofosveset vs.
gadobenate show no advantage of gadofosveset, as long as
the imaging is performed quickly after contrast adminis-
tration [8]. Studies in adults with congenital heart disease
have shown advantages of the use of gadofoseveset [9].
And, though a recent study shows that in adults 3D
inversion recovery bSSFP shows improved image qual-
ity as compared to 3D IR GRE, our experience at our
institution has shown improved imaging with 3D IR
GRE [10]. Studies in the pediatric population are lim-
ited, showing improved pediatric vascular imaging
with gadofosveset and combined respiratory and car-
diac triggering compared to without triggering [3],
and improved pediatric vascular imaging with gado-
fosveset and steady-state MRA compared to first-pass
MRA [11]. We compared image quality of pediatric
vasculature obtained using the standard 3D bSSFP
technique to that obtained with 3D IR GRE imaging
performed after administration of GT, including
patients with repaired congenital heart disease.
Methods
Study population
The current study represents a retrospective review of
all pediatric patients at our institution who underwent
CMR using GT with both pre-contrast 3D bSSFP and
post-contrast 3D IR GRE imaging during the same
examination. Our institution began using GT for clin-
ical CMR evaluations in August 2013, and the present
study included patients from August, 2013 to June,
2014. Patients were excluded if either the 3D bSSFP
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or 3D IR GRE sequence was not completed or if
there was a patient related factor that degraded one
or both imaging sequences. The study was approved
by our local Institutional Review Board.
Image acquisition
All studies were performed on a 1.5 T Siemens Aera mag-
net (Siemens Healthcare, Erlangen, Germany). For both
sequences, vectorcardiographic triggering and respiratory
navigation was used. For both 3D bSSFP and 3D IR GRE,
a high temporal resolution image was used to select the
acquisition period during a quiescent period of the cardiac
cycle, field of view (FOV) and phase FOV were adjusted
to avoid field wrap, voxel sizes were typically 1.2-1.6 mm,
slice thickness was within 0.1 mm of the in-plane reso-
lution to achieve isotropic voxel sizes, and shot duration
and timing were similar between the two sequences. 3D
bSSFP parameters included TE/TR = 1.2/2.8, flip angle =
90°; 3D IR GRE parameters included TE/TR = 1.3/3.3, flip
angle = 18°; IT = 260. Both the 3D bSSFP and the 3D IR
GRE sequences used had been optimized for use by the
magnet manufacturer. For both sequences, respiratory
navigation window was set to achieve 40–60 % image ac-
quisition, and was roughly a 3 mm window for infants,
5 mm for smaller children, and 7 mm for adolescents and
young adults. 3D bSSFP imaging was performed pre-
contrast; 3D IR GRE imaging was performed 5 min after
administration of 0.12 mL/kg (0.03 mmol/kg) GT (max
10 mL). Post-processing was performed using Siemens
Argus software version VD 13.
Image analysis
To evaluate vascular imaging for both 3D bSSFP and
3D IR GRE sequences, a Vascular Imaging Quality
Score (VIQS) system was developed (Table 1), which
focused on key vascular structures for pediatric CMR,
and common issues with image quality. For each pa-
tient, right coronary artery (RCA), left coronary artery
(LCA), pulmonary arteries, pulmonary veins, and
blood pool homogeneity were evaluated with a sub-
score from 0 (worst) to 3 (best), for a maximal “all-
patient VIQS score” of 15. For patients with intratho-
racic metal (including those with sternal wires), a
sixth subscore indicating the amount of artifact
caused by the metal was added, yielding a maximal
“metal VIQS score” of 18. Scoring was performed on
axial reconstructions of the images generated by each
sequence irrespective of the native imaging plane of
acquisition. Image scoring was performed on our in-
stitution’s PACS system on high resolution Barco
monitors to ensure optimal visualization for fine de-
tails. The desire to view all images on the highest
quality format did necessitate unblinding of the study
ID’s for each patient to the reader. To minimize bias,
each study was scored for each VIQS subscore by two
independent readers (AT and TS) at different sittings
separated by at least 24 h for 3D bSSFP and 3D IR
GRE for each patient. Differences in subscores were
adjudicated by a third experienced reader (WJP). Ex-
pected metal object diameter was determined by
using other sequences in the study, as well as the
pre-CMR chest radiograph.
For quantitative analysis, signal- and contrast-to-noise
(SNR and CNR) calculations were performed using
Syngo MultiModality Workplace (Syngo MMWP) ver-
sion VE40A (Siemens Healthcare, Erlangen, Germany).
Regions of interest were drawn on both the axial 3D
bSSFP and 3D IR GRE images in the left ventricular
Table 1 Vascular Imaging Quality Score (VIQS) rubric
0 1 2 3
Right coronary
artery (RCA)




Ostium not seen LCA ostium clear but rest is not LCA bifurcation clear LAD seen along anterior
interventricular groove;




Branch PAs not clearly defined RPA & LPA seen Able to identify RUPA,
RLPA, LUPA, LLPA
Able to identify branches
off of at least 2 of RUPA,
RLPA, LUPA, LLPA












Metal artifact Artifact >300 % of expected
metal object diameter
Artifact >200 % of expected
metal object diameter
Artifact >110 % of expected
metal object diameter,
or asymmetric
Artifact ≤110 % of expected
metal object diameter
Shown is the VIQS scoring rubric. For each vascular structure, the sequence must meet all criteria for lower score to achieve a higher score. The RCA, LCA, PA,
pulmonary vein, and blood pool homogeneity scores comprise the all-patient VIQS score; the metal artifact score is added for the metal VIQS score
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blood pool and myocardium, left atrial blood pool and
posterior wall, and proximal right pulmonary artery and
vessel wall between the right pulmonary artery and the
ascending aorta.
Statistical analysis
Descriptive statistics were calculated for all variables of
interest and included means and standard deviations,
and medians and interquartile ranges. Normality of con-
tinuous variables was assessed using histograms, normal
probability plots, and the Anderson-Darling test for nor-
mality. VIQS scores for each subscore were compared
using the test of symmetry. Image study duration was
compared using paired t-tests. Overall VIQS scores,
changes in image quality based on age, and SNR and
CNR were compared using Wilcoxon signed-rank test-
ing. Non-metal scores stratified by metal artifact scores
and VIQS sores based on age were compared using
Kruskal-Wallis testing. Score variability within sequences
was compared using Brown-Forsythe testing, and inter-
rater agreement was assessed using the weighted kappa
statistic. Statistical analyses were performed using SAS
9.4 (Cary, NC) and statistical significance was assessed
at the 0.05 level.
Results
Patient characteristics
A total of 35 patients completed both 3D bSSFP and
3D IR GRE imaging sequences as part of the same
clinical CMR study during the study period, and com-
prise the all-patient cohort. Of the 35 patients, 17
had intrathoracic metal, and comprise the metal sub-
set cohort. Three other patients were excluded from
the study; one for failed ECG gating; one for patient
movement, and one for contrast extravasation. Of the
35 patients, 9 underwent the study with general
anesthesia and were mechanically ventilated for the
CMR, 9 with conscious sedation who were free
breathing, and 17 without sedation; the type of sed-
ation used was based on clinical indications. The pa-
tients ranged in age from 0.2 to 20.2 years (median
10.7 years, interquartile range (IQR) 5.4–16.1 years).
Patient median weight was 46.0 kg (IQR 18.7–
63.2 kg). Patient median BSA was 1.43 m2 (IQR
0.77–1.65 m2). Patients who underwent the studies
with general anesthesia had a median age of 4.6 years
(IQR 3.1–7.9 years); those with sedation had median
age 6.3 years (IQR 5.3–8.4 years), and those who had
studies without sedation had median age 16.1 years
(IQR 14.8–17.4 years). They represented a broad
range of underlying clinical diagnoses, including 11
patients with aortic arch disease including bicuspid
aortic valve, aortic dilation/aneurysm, and coarctation;
8 patients with concerns for coronary anomalies; 8
patients with single ventricle anatomy who had
undergone Fontan palliation; 5 with repaired tetralogy
of Fallot; 3 with inflammatory vasculopathies includ-
ing Takayasu arteritis or Kawasaki disease; 2 with d-
transposition of the great arteries after an arterial
switch operation; and one patient with a recurrent
left atrial appendage aneurysm (some patients had
multiple clinical indications).
Sequence comparisons
3D IR GRE imaging showed improved overall vascular im-
aging compared to 3D bSSFP for all patients when compar-
ing all-patient VIQS scores (median 14 (IQR 11–15), vs 6
(4–10), p < 0.0001, Fig. 1). When analyzing patients with
intrathoracic metal, 3D IR GRE again showed improved
VIQS (16 (14–17) vs. 5 (2–9), p < 0.0001, Fig. 1). 3D IR
GRE showed significantly improved VIQS subscores for im-
aging the RCA, pulmonary arteries, pulmonary veins, and
blood pool homogeneity (Fig. 2 and Table 2). Of the 140
total vascular structures evaluated, only 6 had a lower VIQS
score on any of structures on the 3D IR GRE sequence
compared to the 3D bSSFP sequence (2 RCA, 4 LCA),
while 64 structures (46 %) showed improvement from a 0
or 1 score in the 3D bSSFP to 2 or 3 score on 3D IR GRE
(Table 3); this improvement was seen for at least a single
vascular structure in 34 of 35 patients. To assess for effects
of metal artifact on other scoring, we stratified the non-
metal VIQS scores by metal artifact score in the metal co-
hort, and there was no significant change in the non-metal
scores based on the metal score. In addition, 3D IR GRE
imaging showed reduced variability in both all-patient and
metal VIQS scores compared to 3D bSSFP (both p < 0.05).
Fig. 1 Overall VIQS score distribution. Shown are the VIQS scores
(median, interquartile range) for the all-patient VIQS scores for all
patients, and metal VIQS scores for the metal cohort, for both 3D
bSSFP and 3D IRE GRE imaging. All-patient and metal subset VIQS
scores were higher for 3D IR GRE imaging compared to 3D bSSFP
imaging (* indicates p < 0.0001)
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Typical example images are shown in Fig. 3. SNR and CNR
were significantly higher for 3D IR GRE compared to 3D
bSSFP in the left ventricle and left atrium (p < 0.0001), but
not the pulmonary arteries (Fig. 4).
3D IR GRE studies had a longer average duration
(7:57 ± 4:06 min vs. 6:02 ± 2:26, p < 0.01). There was no
correlation between heart rate and VIQS for either se-
quence. Inter-rater agreement assessed by the weighted
kappa statistic was considered good on all VIQS sub-
scores except metal artifact (Table 2).
To assess whether the imaging differences were re-
lated to age, patients were stratified based on being
older or younger than 10 years old. Younger patients
had significantly higher 3D IR GRE VIQS scores
than 3D bSSFP scores for all but the LCA, whereas
older patients had higher VIQS scores for all but
RCA, pulmonary arteries, and metal artifacts
(Table 4).
Discussion
We present a method of vascular CMR, post-GT 3D IR
GRE, which we demonstrate to be superior to the stand-
ard pre-contrast 3D bSSFP technique in pediatric patients.
Since vascular imaging in children remains challenging
due to small structure sizes and increased heart rates,
uncovering methods of improved vascular imaging is
Table 2 VIQS scores and statistical testing for 3D bSSPF and 3D IR GRE imaging
3D bSSFP Median (IQR) 3D IR GRE Median (IQR) p-value 3D IR GRE Reduced Variability Weighted Kappa
RCA 1 (0–2) 2 (1–3) 0.031 0.71
LCA 1 (0–3) 3 (1–3) 0.151 0.71
Pulmonary Arteries 3 (1–3) 3 (3–3) 0.041 0.66
Pulmonary Veins 0 (0–1) 3 (3–3) <0.011 0.74
Blood Pool Homogeneity 1 (1–2) 3 (3–3) <0.011 0.71
Metal Artifact 2 (1–2) 2 (2–3) 0.091 0.28
Total All-Patient Score 6 (4–10) 14 (11–15) <0.00012 p = 0.0013
Total Metal Score (n = 17) 5 (2–9) 16 (14–17) <0.00012 p = 0.0433
Shown first are median and interquartile ranges for 3D bSSFP and 3D IR GRE imaging VIQS scores for each vascular structure identified. P-value column indicates
p-value of the test of symmetry for the individual VIQS categories, and results of the Wilcoxon signed-rank test for total VIQS scores. 3D IR GRE Reduced Variability
column shows results of Brown-Forsythe testing for equality of group variances. Weighted kappa column shows kappa values of agreement for each VIQS category.
Bolded p-values are less than 0.05
1Test of symmetry; 2Wilcoxon signed-rank test; 3Brown-Forsythe test
Fig. 2 Individual VIQS scores. Shown are the individual VIQS score distributions for 3D bSSFP and 3D IR GRE imaging for (a) the right coronary
artery; b the left coronary artery; c the pulmonary arteries; d the pulmonary veins; e blood pool homogeneity; and (f) metal artifact
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paramount for our field. In addition, delineation of anat-
omy and size of vascular structures in children is a com-
mon indication for CMR, therefore achieving improved
vascular imaging is clinically relevant.
We found improved overall imaging with 3D IR GRE
in patients with and without metal artifact compared to
3D bSSFP, though the individual metal artifact VIQS
subscore was not significantly improved with 3D IR
GRE. This finding may be due to our metal artifact
VIQS scores having higher inter-rater variability. In
some cases, the imaging quality was so poor, particularly
for 3D SSFP imaging with intrathoracic metal, that it
was difficult to discern the specific causes of image dis-
tortion (e.g. whether the poor imaging was due to metal
artifact or other reasons). However, given that many pa-
tients who are referred for CMR are post-surgical pa-
tients with intrathoracic metal, the improved all-patient
VIQS with the 3D IR GRE technique was reassuring,
even if the differences in the metal artifact subscore
were not statistically significant.
We did have a high rate of VIQS scores of 0 for pul-
monary veins on the 3D bSSFP imaging. The VIQS scor-
ing system we developed requires the ostium of the vein
to be seen clearly entering the left atrium. Given the
high rate of signal inhomogeneity/inflow artifacts in the
pulmonary veins in 3D bSSFP imaging, this resulted in a
number of 0 VIQS scores for pulmonary veins. 3D IR
GRE reduces this artifact, therefore improving pulmon-
ary vein VIQS scores (Fig. 3e-f ).
There are some limitations to the 3D IR GRE tech-
nique. The 3D IR GRE technique did have longer ac-
quisitions on average compared to the 3D bSSFP
technique; however, we believe that the improved vas-
cular imaging justifies the approximately 2 min longer
sequence duration for this cohort. In addition, the in-
version pulse precludes the performance of dual
phase imaging due to insufficient time for two inver-
sion pulses in a single RR interval. Though two 3D
IR GRE sequences, one in systole and one in diastole,
could be run in tandem, we did not investigate this
possibility. We also did not investigate the use of
Fig. 3 Examples of 3D bSSFP and 3D IR GRE imaging. Excellent left coronary artery imaging by both (a) 3D bSSFP and (b) 3D IR GRE imaging; a
patient with pulmonary atresia status post RV-PA conduit with large metal clip artifact on (c) 3D bSSFP, and improved imaging by (d) 3D IR GRE;
a patient without intrathoracic metal with poorly-visualized left pulmonary vein with (e) 3D bSSFP, with improved imaging on 3D IR GRE (f)
Table 3 Improvement of VIQS scores from 0 or 1 on 3D bSSFP
to 2 or 3 on 3D IR GRE
n = 35
RCA 11 (31 %)
LCA 10 (29 %)
Pulmonary Arteries 10 (29 %)
Pulmonary Veins 33 (94 %)
Blood Pool Homogeneity 21 (60 %)
Metal artifact (n = 17) 8 (47 %)
Shown are patients who had a VIQS score of 0 or 1 on 3D bSSFP and 2 or 3
on 3D IR GRE, as a marker of individual VIQS improvements
between sequences
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different inversion times, as the sequence was used as
prescribed by the manufacturer.
Gadofosveset trisodium shows a similar safety pro-
file to standard extracellular gadolinium contrast
agents [12], and can be used similarly to extracellular
agents for first-pass arterial imaging, though GT of-
fers the advantage of higher relaxivity [13]. Gadofos-
veset trisodium’s primary advantage is its increased
duration of intravascular residence, offering the op-
portunity to obtain equilibrium images (up to 45–60
min after injection in adults) [13]. GT’s higher relax-
ivity also allows a smaller total dose of gadolinium to
be given (standard dose is 0.03 mmol/kg), and even
lower doses of GT have been reported as well [14].
No cases of nephrogenic systemic fibrosis have been
reported with GT to date, but given renal clearance,
caution should be used in patients with renal
impairment, similar to extracellular gadolinium con-
trast agents [12, 13].
Gadofosveset trisodium’s protein binding and long
equilibrium state, however, do confer some limitations
to its use. Fibrosis imaging using late gadolinium en-
hancement (LGE) techniques have not been fully estab-
lished with GT. While the principals behind LGE
imaging hold regardless of the specific gadolinium
agent utilized, inversion times and optimal delay be-
tween administration and LGE imaging have not been
well studied with GT [15]. Additionally, the emerging
field of diffuse fibrosis imaging with T1 mapping and
extra-cellular volume (ECV) calculation have funda-
mental assumptions which are violated when using
blood pool contrast agents such as GT. Finally, GT is
currently unavailable for sale. These limitations not-
withstanding, our center had moved toward using
GT-enhanced 3D IR GRE imaging for many of our
pediatric CMR cases due to its improved vascular im-
aging in our population, and will do so again when
GT is available.
Limitations
This study does have limitations. We did not randomize
the patients to be included in the study. Patient condi-
tions may have been slightly different for the pre-
contrast 3D bSSFP and the post-contrast 3D IR GRE,
and due to the nature of the sequences, we were unable
to alter the fact that the 3D bSSFP had to be run first.
Finally, though we did rate the 3D bSSFP and 3D IR
GRE datasets in different sittings, there may have been
some bias introduced by evaluation of the 3D IR GRE
images after the 3D bSSFP.
Conclusion
In this study, we demonstrate improved imaging of
pediatric vascular structures using the post-GT 3D IR
GRE technique compared to the pre-contrast 3D bSSFP
technique. We recommend its use for many common
Table 4 3D bSSFP vs. 3D IR GRE scores for patients based on age
Patients < 10 years old (n = 16) Patients≥ 10 years old (n = 19)
3D bSSFP Median (IQR) 3D IR GRE Median (IQR) p-value 3D bSSFP Median (IQR) 3D IR GRE Median (IQR) p-value
RCA 0 (0 – 1) 2 (1 – 3) 0.002 2 (0 – 3) 3 (1 – 3) 0.113
LCA 1 (0 – 2) 1 (0 – 3) 0.141 2 (0 – 3) 3 (2 – 3) 0.014
Pulmonary Arteries 3 (0 – 3) 3 (3 – 3) 0.008 3 (2 – 3) 3 (3 – 3) 0.063
Pulmonary Veins 0 (0 – 0) 3 (3 – 3) <0.001 1 (0 – 1) 3 (3 – 3) <0.001
Blood Pool Homogeneity 1 (0 – 2) 3 (3 – 3) <0.001 2 (1 – 2) 3 (3 – 3) <0.001
Metal Artifact 2 (1 – 2) 2 (2 – 2) 0.031 2 (1 – 2) 2 (2 – 3) 0.063
Total All-Patient Score 5 (1 – 7) 13 (10 – 14) <0.001 9 (5 – 11) 14 (13 – 15) <0.001
Total Metal Score (n = 17) 3 (2 – 7) 16 (14 – 17) 0.004 9 (5 – 12) 17 (14 – 17) 0.008
Shown are the median (interquartile range) of VIQS scores for each category, based on age of the patient. Bolded p-values are less than 0.05
Fig. 4 Signal- and contrast-to-noise ratios for 3D bSSFP and 3D IR GRE
imaging. Shown are the signal- and contrast-to-noise (SNR and CNR)
distributions across the left ventricle, left atrium, and pulmonary arteries
(LV, LA, and PA) with bars indicating maximum and minimum values.
SNR and CNR ratios were significantly higher in the left ventricle and
left atrium with 3D IR GRE imaging as compared to 3D bSSFP imaging
(* indicates p < 0.0001)
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indications for pediatric CMR. The kinetics of GT do
preclude its use for some applications, such as ECV
calculation with T1 mapping, but if high quality cardiac
and vascular anatomy is the primary clinical question for
the study, GT-enhanced 3D IR GRE imaging should be
considered.
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